A novel machine learning prediction model for metastasis in breast cancer

Author:

Li Huan1,Liu Ren‐Bin1,Long Chen‐meng2,Teng Yuan3,Liu Yu1ORCID

Affiliation:

1. Department of Thyroid and Breast Surgery Third Affiliated Hospital of Sun Yat‐sen University Guangzhou China

2. Department of Breast Surgery Liuzhou Women and Children's Medical Center Liuzhou China

3. Department of Breast Surgery Guangzhou Women and Children's Medical Center Guangzhou China

Abstract

AbstractBackgroundBreast cancer (BC) metastasis is the common cause of high mortality. Conventional prognostic criteria cannot accurately predict the BC metastasis risk. The machine learning technologies can overcome the disadvantage of conventional models.AimWe developed a model to predict BC metastasis using the random survival forest (RSF) method.MethodsBased on demographic data and routine clinical data, we used RSF‐recursive feature elimination to identify the predictive variables and developed a model to predict metastasis using RSF method. The area under the receiver operating characteristic curve (AUROC) and Kaplan–Meier survival (KM) analyses were plotted to validate the predictive effect when C‐index was plotted to assess the discrimination and Brier scores was plotted to assess the calibration of the predictive model.ResultsWe developed a metastasis prediction model comprising three variables (pathological stage, aspartate aminotransferase, and neutrophil count) selected by RSF‐recursive feature elimination. The model was reliable and stable when assessed by the AUROC (0.932 in training set and 0.905 in validation set) and KM survival analyses (p < .0001). The C‐indexes (0.959) and Brier score (0.097) also validated the good predictive ability of this model.ConclusionsThis model relies on routine data and examination indicators in real‐time clinical practice and exhibits an accurate prediction performance without increasing the cost for patients. Using this model, clinicians can facilitate risk communication and provide precise and efficient individualized therapy to patients with breast cancer.

Funder

National Natural Science Foundation of China

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3